Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis Gerke

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate CancerMark A Preston, Julie L Batista, Kathryn M Wilson, et al.
Cancer & Metabolism|December 17, 2016
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control studyRachel S Kelly, Jennifer A Sinnott, Jennifer R Rider, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2018
Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate CancerRobert J Rounbehler, Anders E Berglund, Travis Gerke, et al.
Cancer|July 13, 2017
Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancerEricka M Ebot, Travis Gerke, David P Labbé, et al.
Prostate Cancer and Prostatic Diseases|October 28, 2018
Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancerAnders E Berglund, Robert J Rounbehler, Travis Gerke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 2017
Height, Obesity, and the Risk of <i>TMPRSS2:ERG</i>-Defined Prostate CancerRebecca E Graff, Thomas U Ahearn, Andreas Pettersson, et al.
JCO Clinical Cancer Informatics|February 21, 2020
Cancer Informatics for Cancer Centers (CI4CC): Building a Community Focused on Sharing Ideas and Best Practices to Improve Cancer Care and Patient OutcomesJill S Barnholtz-Sloan, Dana E Rollison, Amrita Basu, et al.
JCO Clinical Cancer Informatics|May 14, 2021
Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt ExperienceSteven A Eschrich, Jamie K Teer, Phillip Reisman, et al.
Journal of the National Cancer Institute|November 29, 2015
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate CancerThomas U Ahearn, Andreas Pettersson, Ericka M Ebot, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Epidemiology|April 30, 2025
Long-term performance of the Gleason score in predicting metastatic and fatal prostate cancerZhike Lin, Konrad H Stopsack, Michelangelo Fiorentino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate CancerMark A Preston, Julie L Batista, Kathryn M Wilson, et al.
Cancer & Metabolism|December 17, 2016
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control studyRachel S Kelly, Jennifer A Sinnott, Jennifer R Rider, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2018
Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate CancerRobert J Rounbehler, Anders E Berglund, Travis Gerke, et al.
Cancer|July 13, 2017
Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancerEricka M Ebot, Travis Gerke, David P Labbé, et al.
Prostate Cancer and Prostatic Diseases|October 28, 2018
Distinct transcriptional repertoire of the androgen receptor in ETS fusion-negative prostate cancerAnders E Berglund, Robert J Rounbehler, Travis Gerke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 24, 2017
Height, Obesity, and the Risk of <i>TMPRSS2:ERG</i>-Defined Prostate CancerRebecca E Graff, Thomas U Ahearn, Andreas Pettersson, et al.
JCO Clinical Cancer Informatics|February 21, 2020
Cancer Informatics for Cancer Centers (CI4CC): Building a Community Focused on Sharing Ideas and Best Practices to Improve Cancer Care and Patient OutcomesJill S Barnholtz-Sloan, Dana E Rollison, Amrita Basu, et al.
JCO Clinical Cancer Informatics|May 14, 2021
Enabling Precision Medicine in Cancer Care Through a Molecular Data Warehouse: The Moffitt ExperienceSteven A Eschrich, Jamie K Teer, Phillip Reisman, et al.
Journal of the National Cancer Institute|November 29, 2015
A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate CancerThomas U Ahearn, Andreas Pettersson, Ericka M Ebot, et al.
Pageof 7